Live from the Hematology Debate in Rome: A focus on CLL
A focus on first-line treatment options for CLL: an update from ASH 2016
Agenda
Chair: Paolo Ghia (Italy)
Speakers: Paolo Ghia (Italy) and Steven Coutre (USA)
After participating in this broadcast, you should be able to:
• Discuss recent clinical data relating to treatment-naïve CLL and its potential impact on daily clinical practice.